Compare HOTH & DDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
DDC Enterprise Ltd is a content driven consumer brand offering easy, convenient ready-to-heat , ready-to-cook and plant-based meal products i.e. meal products consisting largely or solely of vegetables, fruits, grains and other foods derived from plant-based protein, rather than animal protein) while promoting healthier lifestyle choices to Millennial and Generation Z customer-base. It is also engaged in the provision of advertising services and the operation of experience stores to offer cooking classes.